Alzheimer Disease Clinical Trial
Official title:
Correlation of Musicality and Cognitive Skills in Persons With Alzheimer´s Disease
Correlation of musicality, brain atrophy in brain areas relevant for music processing and the stage of Alzheimer´s disease.
Alzheimer's disease (AD) is the most common cause of dementia accounting for 60-70% of all
dementias. In most cases the cause for AD is unknown. The progression of AD is characterized
by an advancing decline in cognitive skills and symptoms like impaired learning, memory
deficits, language impairment and behavioral disturbances in later stages. The symptoms of AD
are caused by cerebral atrophy which is the consequence of multiple pathological processes,
including the formation of neurofibrillary tangles at neurites and amyloid plaques in the
walls of cerebral blood vessels. AD is a major public health issue and its significance
increases as the population grows older.
Music is thought to have preceded the development of spoken language as a form of
communication and it has been used for therapeutic purposes in many ways throughout history.
In patients with AD, musical memory has been noticed to be well-preserved and constituting a
relatively independent part of memory. Music-based neurological rehabilitation provides a
mode of treatment, which is free of side effects and can be personalized for patients with
dementia.
Aims of this study are to examine how AD affects the structure of various brain areas
associated with music processing and to statistically correlate musical cognition with memory
performance in patients with AD. Focus is on brain areas associated with musical pleasure
like the striatum, superior temporal gyrus, inferior frontal gyrus and areas associated with
long-term musical memory like the anterior cingulate gyrus and presupplementary motor area.
Hippocampal atrophy serves as a reference of the stage of AD. Our working hypothesis is that
musicality correlates with preserved cognitive skills and memory.
Voluntary participants who have been diagnosed with AD are recruited from Turku University
Central Hospital. Their musicality is assessed with a short version of Montreal Battery of
Evaluation of Amusia which contains listening tasks that test the patients' memory, rhythm
recognition and pitch discrimination. In addition, patients are asked to fill an inquiry that
maps their use of music and its significance in their daily lives. Voxel-Based Morphometry is
applied on MRI images to evaluate atrophy in the hippocampus and entorhinal cortex, which
correlate with clinical stages of AD, as well as on the brain areas relevant for processing
of music.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04044495 -
Sleep, Rhythms and Risk of Alzheimer's Disease
|
N/A | |
Completed |
NCT04079803 -
PTI-125 for Mild-to-moderate Alzheimer's Disease Patients
|
Phase 2 | |
Terminated |
NCT03052712 -
Validation and Standardization of a Battery Evaluation of the Socio-emotional Functions in Various Neurological Pathologies
|
N/A | |
Recruiting |
NCT04520698 -
Utilizing Palliative Leaders In Facilities to Transform Care for Alzheimer's Disease
|
N/A | |
Active, not recruiting |
NCT04606420 -
Can Lifestyle Changes Reverse Early-Stage Alzheimer's Disease
|
N/A | |
Recruiting |
NCT05820919 -
Enhancing Sleep Quality for Nursing Home Residents With Dementia - R33 Phase
|
N/A | |
Terminated |
NCT03672474 -
REGEnLIFE RGn530 - Feasibility Pilot
|
N/A | |
Completed |
NCT03430648 -
Is Tau Protein Linked to Mobility Function?
|
||
Recruiting |
NCT05557409 -
A Study to Assess the Efficacy and Safety of AXS-05 in Subjects With Alzheimer's Disease Agitation
|
Phase 3 | |
Recruiting |
NCT05288842 -
Tanycytes in Alzheimer's Disease and Frontotemporal Dementia
|
||
Recruiting |
NCT04949750 -
Efficacy of Paper-based Cognitive Training in Vietnamese Patients With Early Alzheimer's Disease
|
N/A | |
Recruiting |
NCT04522739 -
Spironolactone Safety in African Americans With Mild Cognitive Impairment and Early Alzheimer's Disease
|
Phase 4 | |
Completed |
NCT06194552 -
A Multiple Dose Study of the Safety and Pharmacokinetics of NTRX-07
|
Phase 1 | |
Completed |
NCT03239561 -
Evaluation of Tau Protein in the Brain of Participants With Alzheimer's Disease Compared to Healthy Participants
|
Early Phase 1 | |
Completed |
NCT03184467 -
Clinical Trial to Evaluate the Efficacy and Safety of GV1001 in Alzheimer Patients
|
Phase 2 | |
Active, not recruiting |
NCT03676881 -
Longitudinal Validation of a Computerized Cognitive Battery (Cognigram) in the Diagnosis of Mild Cognitive Impairment and Alzheimer's Disease
|
||
Terminated |
NCT03487380 -
Taxonomic and Functional Composition of the Intestinal Microbiome: a Predictor of Rapid Cognitive Decline in Patients With Alzheimer's Disease
|
N/A | |
Completed |
NCT05538455 -
Investigating ProCare4Life Impact on Quality of Life of Elderly Subjects With Neurodegenerative Diseases
|
N/A | |
Recruiting |
NCT05328115 -
A Study on the Safety, Tolerability and Immunogenicity of ALZ-101 in Participants With Early Alzheimer's Disease
|
Phase 1 | |
Completed |
NCT05562583 -
SAGE-LEAF: Reducing Burden in Alzheimer's Disease Caregivers Through Positive Emotion Regulation and Virtual Support
|
N/A |